Corticosteroid-sparing effects of nedocromil sodium in asthma management
Author Information
Author(s): A. F. Capristo, M. Miraglia del Giudice Jr., C. Alfaro, N. Maiello
Primary Institution: Paediatric Clinic, University of Naples
Hypothesis
Can nedocromil sodium provide a steroid-sparing effect in children with asthma?
Conclusion
Nedocromil sodium may reduce the need for corticosteroids in long-term asthma management.
Supporting Evidence
- Nedocromil sodium was shown to be equally or more effective than sodium cromoglycate.
- The study involved a wash-out period of at least 2 months before treatment.
- Children were randomly allocated to treatment groups for a cross-over design.
- Significant improvement in bronchial hyper-responsiveness was noted with nedocromil.
- High doses of inhaled steroids are associated with increased side effects.
Takeaway
This study looked at how a medicine called nedocromil can help kids with asthma without needing as many steroids, which can have side effects.
Methodology
A double-blind, placebo-controlled, cross-over study comparing nedocromil sodium and beclomethasone dipropionate in children with asthma.
Potential Biases
Potential bias in self-reported outcomes and small sample size.
Limitations
The study did not assess the long-term effects beyond the treatment period.
Participant Demographics
Children aged 8-13 years, with a mix of 12 females and 18 males.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website